|
EP0377676B1
(en)
|
1987-09-17 |
1995-05-24 |
Massachusetts Institute Of Technology |
Human erythroid-specific transcriptional enhancer
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
JP3866760B2
(ja)
|
1993-02-22 |
2007-01-10 |
ザ ロックフェラー ユニバーシティ |
一過性トランスフェクションによる高力価のヘルパーフリーのレトロウイルスの生産
|
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
|
DE69435223D1
(de)
|
1993-10-25 |
2009-09-03 |
Canji Inc |
Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung
|
|
US5484720A
(en)
|
1994-09-08 |
1996-01-16 |
Genentech, Inc. |
Methods for calcium phosphate transfection
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
US6027721A
(en)
|
1996-05-20 |
2000-02-22 |
Cytotherapeutics, Inc. |
Device and method for encapsulated gene therapy
|
|
US5952190A
(en)
|
1996-10-04 |
1999-09-14 |
Fanconi Anemia Research Fund, Inc. |
cDNA for fanconi anemia complementation group A
|
|
US6136597A
(en)
|
1997-09-18 |
2000-10-24 |
The Salk Institute For Biological Studies |
RNA export element
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
US20020065236A1
(en)
|
1998-09-09 |
2002-05-30 |
Yew Nelson S. |
CpG reduced plasmids and viral vectors
|
|
US7994278B1
(en)
|
1999-08-06 |
2011-08-09 |
Nobel Biosciences Llc |
Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
|
|
HK1048302A1
(zh)
|
1999-08-13 |
2003-03-28 |
大正制药株式会社 |
前列腺素衍生物
|
|
HK1050210B
(en)
|
1999-10-12 |
2007-08-24 |
Institut Pasteur |
Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
|
|
US20020013294A1
(en)
|
2000-03-31 |
2002-01-31 |
Delong Mitchell Anthony |
Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
|
|
AU2001263006A1
(en)
|
2000-05-18 |
2001-11-26 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
|
US6627442B1
(en)
|
2000-08-31 |
2003-09-30 |
Virxsys Corporation |
Methods for stable transduction of cells with hiv-derived viral vectors
|
|
GB0024550D0
(cg-RX-API-DMAC10.html)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
|
ATE527347T1
(de)
|
2001-08-02 |
2011-10-15 |
Inst Clayton De La Rech |
Verfahren und zusammensetzungen im zusammenhang mit verbesserten lentivirusvektor- produktionssystemen
|
|
CA2462628C
(en)
|
2001-10-02 |
2019-08-20 |
Institut Clayton De La Recherche |
Restricted expression lentiviral vectors
|
|
US20060051755A1
(en)
|
2002-04-15 |
2006-03-09 |
Rigel Pharmaceuticals |
Methods of assaying for cell cycle modulators
|
|
ATE446077T1
(de)
|
2002-05-02 |
2009-11-15 |
Univ Rochester |
Vektoren mit beiden isoformen von beta- hexosaminidase
|
|
WO2004094642A2
(en)
|
2003-04-24 |
2004-11-04 |
Fondazione Centro San Raffaele Del Monte Tabor |
Lentiviral vectors carrying synthetic bi-directional promoters and uses thereof
|
|
JP2007054069A
(ja)
|
2005-08-24 |
2007-03-08 |
Medizinische Hochschule Hannover |
自己不活性化レトロウイルスベクター
|
|
BE1016793A4
(fr)
|
2005-10-04 |
2007-06-05 |
Artelis |
Procede de culture de cellules et dispositif permettant sa mise en oeuvre.
|
|
US8324367B2
(en)
|
2006-11-03 |
2012-12-04 |
Medtronic, Inc. |
Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity
|
|
WO2008136670A2
(en)
|
2007-05-02 |
2008-11-13 |
Erasmus University Medical Center Rotterdam |
Improved methods and means for lentiviral gene delivery
|
|
AU2008262478B9
(en)
|
2007-05-29 |
2014-06-19 |
Aldevron, L.L.C. |
Vectors and methods for genetic immunization
|
|
EP2520643B8
(en)
|
2007-12-07 |
2019-11-27 |
Miltenyi Biotec B.V. & Co. KG |
Sample processing systems and methods
|
|
DE102008063606A1
(de)
|
2008-12-18 |
2010-06-24 |
Eufets Ag |
Ein-Vektor Tet-System und dessen Verwendung
|
|
WO2010126766A1
(en)
|
2009-04-30 |
2010-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inducible interleukin-12
|
|
DE102009021592A1
(de)
|
2009-05-15 |
2010-11-18 |
Medizinische Hochschule Hannover |
ASLV-Vektorsystem
|
|
WO2010138750A2
(en)
|
2009-05-27 |
2010-12-02 |
The Salk Institute For Biological Studies |
Generation of genetically corrected disease-free induced pluripotent stem cells
|
|
JP5996429B2
(ja)
|
2009-09-03 |
2016-09-21 |
ジェネンテック， インコーポレイテッド |
関節リウマチの治療、診断及びモニターするための方法
|
|
EP2486137B1
(en)
|
2009-10-05 |
2018-05-30 |
Ya-Fang Mei |
Replication-competent ad11p based viral vectors
|
|
RU2638802C2
(ru)
|
2011-05-16 |
2017-12-15 |
Джензим Корпорейшн |
Применение антагонистов cxcr4
|
|
EP3868888A1
(en)
|
2012-02-29 |
2021-08-25 |
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) |
Retroviral transduction using poloxamers
|
|
CN116622704A
(zh)
|
2012-07-25 |
2023-08-22 |
布罗德研究所有限公司 |
可诱导的dna结合蛋白和基因组干扰工具及其应用
|
|
US10280391B2
(en)
|
2012-12-11 |
2019-05-07 |
Pall Technology Uk Limited |
Recipient for cell cultivation
|
|
KR102955556B1
(ko)
|
2012-12-12 |
2026-04-22 |
더 브로드 인스티튜트, 인코퍼레이티드 |
서열 조작을 위한 crispr-cas 성분 시스템, 방법 및 조성물
|
|
US20160194660A1
(en)
|
2012-12-21 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Expression vectors for recombinant protein production in mammalian cells
|
|
EP2792742A1
(en)
|
2013-04-17 |
2014-10-22 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
Gene-therapy vectors for treating cardiomyopathy
|
|
CN104419683A
(zh)
|
2013-09-10 |
2015-03-18 |
中国科学院生物物理研究所 |
制备范可尼贫血症患者自体诱导多能干细胞的方法及其应用
|
|
GB201318347D0
(en)
|
2013-10-16 |
2013-11-27 |
Ucl Business Plc |
Retroviral vectors
|
|
WO2015073922A2
(en)
|
2013-11-15 |
2015-05-21 |
Northwestern University |
Inhibition of oxidative stress in atrial fibrillation
|
|
CA2947466A1
(en)
|
2014-05-01 |
2015-11-05 |
University Of Washington |
In vivo gene engineering with adenoviral vectors
|
|
WO2015179540A1
(en)
|
2014-05-20 |
2015-11-26 |
Regents Of The University Of Minnesota |
Method for editing a genetic sequence
|
|
US11030531B2
(en)
*
|
2014-06-06 |
2021-06-08 |
Trustees Of Boston University |
DNA recombinase circuits for logical control of gene expression
|
|
GB201417042D0
(en)
|
2014-09-29 |
2014-11-12 |
Fkd Therapies Oy |
Method
|
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
|
US10350245B2
(en)
|
2015-01-21 |
2019-07-16 |
Fred Hutchinson Cancer Research Center |
Point-of-care and/or portable platform for gene therapy
|
|
MA41506A
(fr)
|
2015-02-13 |
2017-12-19 |
Takeda Vaccines Inc |
Procédés de production de virus pour produire des vaccins
|
|
MX2017011615A
(es)
|
2015-03-10 |
2018-04-11 |
Univ Columbia |
Construcciones de vectores virales adeno-asociados de glut1 recombinantes y métodos relacionados para restablecer la expresión de glut1.
|
|
WO2016183593A2
(en)
|
2015-05-14 |
2016-11-17 |
The Regents Of The University Of California |
Prenatal therapy
|
|
WO2017083750A1
(en)
|
2015-11-11 |
2017-05-18 |
Intrexon Corporation |
Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies
|
|
EP3405215B1
(en)
|
2016-01-19 |
2022-06-15 |
The Regents of the University of California |
Methods for the treatment of danon disease and other disorders of autophagy
|
|
CA3011939A1
(en)
|
2016-02-02 |
2017-08-10 |
University Of Massachusetts |
Method to enhance the efficiency of systemic aav gene delivery to the central nervous system
|
|
KR20250134722A
(ko)
|
2016-02-12 |
2025-09-11 |
블루버드 바이오, 인코포레이티드. |
Vcn 인핸서 조성물 및 이의 사용 방법
|
|
RS67367B1
(sr)
|
2016-04-14 |
2025-11-28 |
Ferring Ventures Ltd |
Bioreaktor sa fiksiranim slojem sa pumpom/sistemom creva sa konstantnim protokom
|
|
KR102673203B1
(ko)
*
|
2016-04-20 |
2024-06-10 |
센트로 데 인베스띠가씨오네스 에너제티까스 메디오암비엔딸레스 와이 테크놀로지까스, 오.에이., 엠.피. |
Pklr의 유전자 발현 증강을 위한 조성물 및 방법
|
|
US20220323612A1
(en)
|
2016-06-13 |
2022-10-13 |
Bluebird Bio, Inc. |
Gene therapy of neuronal ceroid lipofuscinoses
|
|
US20190345450A1
(en)
|
2016-06-17 |
2019-11-14 |
Fred Hutchinson Cancer Research Center |
Strategies to assess and/or produce cell populations with predictive engraftment potential
|
|
IL320371A
(en)
|
2016-09-08 |
2025-06-01 |
Centro De Investig Energeticas Medioambientales Y Tecnologicas O A M P |
Gene therapy for patients with fanconi anemia
|
|
CN110199028A
(zh)
|
2016-12-06 |
2019-09-03 |
蓝鸟生物公司 |
用于ii型黏多糖贮积症的基因治疗
|
|
MX2019006552A
(es)
|
2016-12-06 |
2019-10-15 |
Bluebird Bio Inc |
Terapia génica para mucopolisacaridosis de tipo i.
|
|
US20180326022A1
(en)
|
2017-04-21 |
2018-11-15 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for improving heart function and treating heart failure
|
|
EP3615044A4
(en)
|
2017-04-27 |
2021-01-20 |
Fred Hutchinson Cancer Research Center |
THERAPEUTIC FORMULAS CONTAINING CD34 + STEM CELLS DERIVED FROM NEGATIVE SELECTION
|
|
AU2018352583B2
(en)
|
2017-10-16 |
2025-04-17 |
Centro de Investigaciones Energeticas, Medioambientales Y Tecnologicas, O.A., M.P. |
Lentiviral vectors for delivery of PKLR to treat Pyruvate Kinase Deficiency
|
|
US12539316B2
(en)
|
2018-04-11 |
2026-02-03 |
Spacecraft Seven, Llc |
Compositions and methods for stem cell transplant
|
|
IL278213B2
(en)
|
2018-04-27 |
2026-04-01 |
Rocket Pharmaceuticals Ltd |
A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd)
|
|
EP3820537A4
(en)
|
2018-07-12 |
2022-04-13 |
Spacecraft Seven, LLC |
GENE THERAPY VECTORS FOR TREATMENT OF DANON DISEASE
|
|
IL280465B2
(en)
|
2018-07-30 |
2025-03-01 |
Centro De Investig Energeticas Medioambientales Y Tecnologicas O A M P |
Methods for gene modification of hematopoietic cells
|
|
JP2021533831A
(ja)
|
2018-08-16 |
2021-12-09 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
ウイルスベクターのための生成方法
|
|
US20220143215A1
(en)
|
2019-02-12 |
2022-05-12 |
Spacecraft Seven, Llc |
Gene therapy vectors for treatment of danon disease
|
|
KR20220012266A
(ko)
|
2019-05-23 |
2022-02-03 |
스페이스크래프트 세븐, 엘엘씨 |
영아 악성 골화석증을 위한 유전자 요법 벡터
|
|
CA3177341A1
(en)
|
2020-05-20 |
2021-11-25 |
Chester Bittencort SACRAMENTO |
Engineered parkin and uses thereof
|
|
WO2022017630A1
(en)
|
2020-07-23 |
2022-01-27 |
Ucl Business Ltd |
GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF
|
|
AU2021321412A1
(en)
|
2020-08-05 |
2023-04-06 |
Spacecraft Seven, Llc |
Adeno-associated viral vector for GLUT1 expression and uses thereof
|
|
IL300187A
(en)
|
2020-08-05 |
2023-03-01 |
Spacecraft Seven Llc |
Gene therapy CSRP3 (protein 3 rich in cysteine and glycine)
|
|
WO2022032226A1
(en)
|
2020-08-07 |
2022-02-10 |
Spacecraft Seven, Llc |
Plakophilin-2 (pkp2) gene therapy using aav vector
|
|
CN116887868A
(zh)
|
2020-12-07 |
2023-10-13 |
太空飞船七有限责任公司 |
达农病的治疗
|
|
CA3240080A1
(en)
|
2021-12-08 |
2023-06-15 |
Christopher Dean HERZOG |
Junctophilin-2 (jph2) gene therapy using aav vector
|
|
CA3240616A1
(en)
|
2021-12-10 |
2023-06-15 |
Christopher Dean HERZOG |
Troponin c (tnnc1) gene therapy using aav vector
|
|
MX2024009685A
(es)
|
2022-02-08 |
2024-08-19 |
Spacecraft Seven Llc |
Vector viral adenoasociado para la expresion de glut1 y usos del mismo.
|
|
JP2025512574A
(ja)
|
2022-04-22 |
2025-04-17 |
スペースクラフト セブン リミテッド ライアビリティ カンパニー |
ＡＡＶベクターを使用するＢ細胞リンパ腫２関連Ａｎｔｈａｎｏｇｅｎｅ ３ （ＢＡＧ３）遺伝子治療
|